Trial update
A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS): registry status update
The registry reports terminated. This is trial metadata, not an assessment of treatment benefit.